I am a physician scientist with interest in Oncology clinical research / trials.
Currently, I am a Postdoctoral Research Fellow at the University of Massachusetts (UMass)
Medical School (Brian C. Lewis lab), Adjunt Member of the Pancreas Program at the UMass
Memorial Cancer Center of Excellence, and Member of the Center for Clinical &
Translational Science at UMass Medical School. 

My professional education and previous training consist of BS degree (1995-1999, Biology)
from the University of Puerto Rico (UPR) at Rio Piedras, MD degree (1999-2004, Research
Pathway) from the UPR School of Medicine, Clinical Internship (2004-2005, Internal
Medicine) from the UPR School of Medicine, MSc degree (2005-2007, Clinical Research) from
the UPR Medical Sciences Campus, and Research Training (2007-2008, Internal Medicine)
from the UPR School of Medicine. 

Through every stage of my education and training, I have performed basic and clinical
research in diverse fields: pancreatic, colorectal, breast, and skin cancers, chronic
hepatitis C, rheumatoid arthritis, inflammatory bowel disease, drug addiction, medical
ethics, among others. The research findings from my work have been extensively published
and presented. As a product of my work, I have received multiple honors, awards, and
scholarships. 

In addition, I have participated in multiple courses, seminars, and workshops that enrich
my experience. My biomedical research experience has allowed me to serve as a clinical
research teacher, consultant, reviewer, and judge in multiple basic and clinical research
presentations events and school science fairs. 

My contact e-mail is wilfredodejesusmonge@yahoo.com . 

You can visit my LinkedIn profile at http://www.linkedin.com/in/wilfredodejesusmonge .

Articles

Link

The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis. (with M. Rajurkar, D. R. Driscoll, V. A. Appleman, H. Huang, J. L. Cotton, D. S. Klimstra, L. J. Zhu, K. Simin, L. Xu, A. P. McMahon, B. C. Lewis, and J. Mao), Proc Natl Acad Sci U S A (2012)
 
Cancer clinical trials: a primer for patients and health care providers (with M. Tirado-Gomez), Buhiti (2011)
 

Link

Age as a deciding factor in the consideration of futility for a medical intervention in patients among Internal Medicine physicians in two practice locations (with D. M. Cruz-Oliver, D. R. Thomas, T. K. Malmstrom, and M. A. Paniagua), J Am Med Dir Assoc (2010)

OBJECTIVES: This study explores physicians' concepts of futility and use of age as a deciding...

 

Link

Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico (with C. Gonzalez-Keelan, R. Zhao, S. R. Hamilton, M. Rodriguez-Bigas, and M. Cruz-Correa), Fam Cancer (2010)

Colorectal cancer (CRC) is a leading cause of morbidity and mortality and alterations in mismatch...

 

Link

[Mouse models of human cancer: valuable tools for oncological research] (Spanish), Galenus (2010)

[En Puerto Rico, en el 2008, el cáncer fue la segunda causa de muerte, después...

 

View More »

Book contributions

Cutaneous manifestations of gastrointestinal diseases (with M. I. Vazquez-Roque), Atlas of Dermatology in Internal Medicine (2012)
 
[My experience as a cancer researcher] (Spanish), [Boricuan Science: Essays and Anecdotes of the Puerto Rican Scientist] (Spanish) (2011)
 

Link

[The science fair: your first experience in research] (Spanish), [Boricuan Science: Essays and Anecdotes of the Puerto Rican Scientist] (Spanish) (2011)

[La feria científica escolar es la exhibición de proyectos que utilizan el método científico. La...

 
Developing a research study plan, Quick research guide (in CD) (2008)
 
How to write a proposal for Institutional Review Board (IRB), Quick research guide (in CD) (2008)
 

Selected cancer-related published abstracts

Link

Complementary and alternative medicine in the treatment of colorectal and pancreatic cancers: promising therapies for the future (Abstract P6), J Investig Med 2008;56:814 (2008)

Purpose of Study: Colorectal and pancreatic cancers were estimated to be the third and fourth...

 

Link

Complementary and alternative medicine in the treatment of colorectal cancer: a systematic review on this promising therapy (Abstract P-273), Ann Oncol 2008;19(Suppl 6):vi98 (2008)

Background: Colorectal cancer is a common malignancy with an annual incidence of over 945,000 cases...

 

Link

DNA mismatch repair gene mutation: a common genetic link between colorectal and pancreatic cancers (Abstract P1), J Investig Med 2008;56:812 (2008)
 

Additional cancer-related presentations

Change in international pancreatic cancer incidence and mortality rates. Center for Clinical & Translational Science Research Retreat, UMass Medical School, Worcester, MA (with B. A. Barton) (2012)
 
Descriptive analysis of racial/ethnic differences in subject enrollment for cancer clinical trials. Multidisciplinary Conference in Clinical Research and Summit of Translational Research in Health Disparities, University of Puerto Rico Medical Sciences Campus, San Juan, PR, 2012; Clinical and Translational Research Symposium, Vermont Cancer Center, The University of Vermont and Fletcher Allen Health Care, Burlington, VT, 2011 (2012)
 
Female breast cancer in New England: Incidence, mortality, and prevention trends with attention to potential cancer racial/ethnic differences. New England Science Symposium, Harvard Medical School, Boston, MA, 2012. Clinical and Translational Research Symposium, Vermont Cancer Center, The University of Vermont and Fletcher Allen Health Care, Burlington, VT, 2011 (with V. M. De Jesus-Monge) (2012)
 
Involvement of canonical Wnt/β-catenin signaling pathway in pancreatic ductal adenocarcinoma. AACR Annual Meeting, Chicago, IL (with M. Sano, D. Driscoll, D. S. Klimstra, and B. C. Lewis) (2012)
 
Cancer in Worcester, MA: Incidence and mortality trends with a look at racial/ethnic differences. Clinical and Translational Research Symposium, Vermont Cancer Center, The University of Vermont and Fletcher Allen Health Care, Burlington, VT (2011)
 

View More »